April 9 (Reuters) - Johnson & Johnson will ship
relatively few COVID-19 shots around the United States until it
receives regulatory clearance for a large vaccine plant in
Baltimore that has struggled to meet quality control standards,
a top White House Health official said on a Friday press
conference.
J&J is working closely with regulators to resolve the issues
holding up authorization, said Jeff Zients, the White House's
COVID-19 response coordinator. It expects to start shipping 8
million doses per week towards the end of April and remains on
track to deliver around 100 million shots by the end of May, he
added.
(Reporting by Carl O'Donnell)